< Back to Front Page Text size +

Today's Globe: stents studies, super surprise, cutting preemie risk, epilepsy drug warning

Posted by Elizabeth Cooney February 1, 2008 07:03 AM

A turnabout in Swedish studies of drug-coated stents illustrates how billions of dollars in medical sales can hinge on such research. It also demonstrates how scientists can draw seemingly conflicting conclusions, based on small differences in the design or interpretation of studies, creating confusion for doctors and patients alike.

Children's Hospital Boston's Children's Miracle Network gave 10-year-old David Youngerman, an ambassador for the hospital who gives talks about his health story, tickets for his first game: the Super Bowl.

Doctors can cut the risk of cerebral palsy in half for very premature babies by giving their mothers magnesium sulfate just before they give birth, new research shows.

Epilepsy drugs used by millions of people may increase the risk of suicidal thoughts or behavior, the Food and Drug Administration warned yesterday in an alert to doctors.

  • CommentComment
  • EmailEmail
add your comment
Required
Required (will not be published)

This blogger might want to review your comment before posting it.

about white coat notes We post updates every weekday about the region's hospitals, labs and medical schools – covering everything from the latest research findings to what's on the minds of the innovative doctors, nurses and scientists who work here. Send news items and tips to whitecoat@globe.com

Contributors

blogger

Elizabeth Cooney is a former health reporter for the Worcester Telegram & Gazette, where she also was a business reporter and an editor. Earlier in her career, she edited medical books and journals at Little, Brown, and worked for Boston magazine.

Boston Globe Health and Science staff:

archives